Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women. - Test2 - elhamkhani - TriplyDB

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

http://www.wikidata.org/entity/Q30838964

about

Phytoestrogens for menopausal vasomotor symptoms Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat.Review article: health benefits of some physiologically active ingredients and their suitability as yoghurt fortifiers Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal women Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.Investigating the optimal soy protein and isoflavone intakes for women: a perspective.

P2860

Q24201856-D66EFA16-2B70-427E-A0A0-3BF8D55BA434 Q34066353-D6C90134-8988-4963-8DC0-FD1431883F7C Q35420301-7A9040CA-EBBC-429D-BC83-DFE4623D7FB8 Q35783517-517E21B1-AD70-4EE3-8963-4CA636873E4D Q35950597-F4797E6E-B0C6-48ED-89FB-6A0862E06BF9 Q36744585-D54BEAB1-C7CA-40BE-9D58-B926B49CA8A2 Q37346147-521AC686-B559-45D2-9823-A39A502E2A4B

P2860

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

http://www.wikidata.org/entity/Q30838964

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@ast

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@en

type

label

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@ast

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@en

prefLabel

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@ast

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@en

P1433

Q30838964-14D5631D-1AFC-4966-99F4-3FBD7FEDB0FC

P1476

Q30838964-8F573C2E-4026-4852-90ED-3C1B0B679912

P2093

Q30838964-0BAD2499-CF15-4A28-A989-16CAE1DD84F4

Q30838964-31C2D11F-F4E1-4CC8-B322-8B008D1F70AD

Q30838964-5FC4A0C4-09B6-4CB7-AFA7-7B766BEEF7D5

Q30838964-64B6345A-F012-4E91-8803-7F5FA8194214

Q30838964-670C8811-1D2A-412E-94F0-7CC1047F49ED

Q30838964-FC6C7D77-D74E-4FD2-902B-A418782E0C4A

P2860

Q30838964-0F558D5C-46E5-4F58-B85C-D67E6DBE6170

Q30838964-1417B4B2-DAD2-4A72-BA0D-9A6EFBA9798B

Q30838964-17444E69-3A2A-4EC4-92F1-225AC35A1FFC

Q30838964-178B46ED-08E2-49ED-8552-718064BD4845

Q30838964-2001BDA2-7DD0-4AC1-A660-F56D4A88FA0C

Q30838964-2373B59D-33A8-44E3-A01D-A9EAF2639880

Q30838964-2A0E7C64-D1DE-43E5-894D-0E4F4F1C72A9

Q30838964-37928A45-36AF-465B-B194-789ED3BE3D8A

Q30838964-4955F822-4CBB-4D55-A871-BAE9227CAAD4

Q30838964-59E76B49-BC11-472E-A34E-5CED89E10BFE

P304

Q30838964-EB95B7D0-32AF-4024-AB87-B2683DEB6F14

P31

Q30838964-019E4E72-6615-4A46-8418-7B81D3777B2C

P356

Q30838964-E03AF559-8E0A-4D8F-8BB7-EADAA0EDD3E2

P433

Q30838964-883D8EA4-403B-49D5-A52C-0B5F1EAB7E55

P478

Q30838964-03B34F3F-4A75-4272-B7E9-E4CDE6BE8900

P50

Q30838964-52E10867-1DA2-4B05-9549-4FBBCBF824A6

P577

Q30838964-223CD6E9-FD9C-4EDA-AD59-3FE01B630DB7

P698

Q30838964-98F45BC5-92E6-4945-8F1B-D264EF825355

P921

Q30838964-5C293277-5881-4C1B-85D0-F1003FAFBFC7

P356

13697130701750123

P1433

P1476

Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.

@en

P2093

B P Comerford

http://www.w3.org/2001/XMLSchema#string

H Nawaz

http://www.w3.org/2001/XMLSchema#string

M A Evans

http://www.w3.org/2001/XMLSchema#string

M L Hoxley

http://www.w3.org/2001/XMLSchema#string

P M Sarrel

http://www.w3.org/2001/XMLSchema#string

V Yanchou Njike

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Raloxifene and endothelial function in healthy postmenopausal women.

Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.

American College of Preventive Medicine Practice Policy Statement: perimenopausal and postmenopausal hormone replacement therapy.

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease.

Hormone replacement therapy and coronary heart disease in women: a review of the evidence.

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.

P304

500-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13697130701750123

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18049943

http://www.w3.org/2001/XMLSchema#string

P921